Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Washington University School of Medicine
Stanford University
Milton S. Hershey Medical Center
Centre Antoine Lacassagne
Ohio State University Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Milton S. Hershey Medical Center
CancerCare Manitoba
OHSU Knight Cancer Institute
University of Texas Southwestern Medical Center
NYU Langone Health
Mayo Clinic
Abramson Cancer Center at Penn Medicine
The Netherlands Cancer Institute
Beth Israel Medical Center
Mayo Clinic